BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17078381)

  • 1. Development of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Boztug K; Dewey RA; Klein C
    Curr Opin Mol Ther; 2006 Oct; 8(5):390-5. PubMed ID: 17078381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome.
    Rai R; Romito M; Rivers E; Turchiano G; Blattner G; Vetharoy W; Ladon D; Andrieux G; Zhang F; Zinicola M; Leon-Rico D; Santilli G; Thrasher AJ; Cavazza A
    Nat Commun; 2020 Aug; 11(1):4034. PubMed ID: 32788576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Wiskott Aldrich syndrome protein in haematological malignancies: genetics, molecular mechanisms and therapeutic strategies.
    R P; Shanmugam G; Rakshit S; Sarkar K
    Pathol Res Pract; 2024 Jan; 253():155026. PubMed ID: 38118219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
    Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
    Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report.
    Pury S; López Orozco M; Pichichero G; Sasia LV; Morell D; Álvarez MS; Basquiera AL; Mas ME; Salvucci K
    Arch Argent Pediatr; 2024 Feb; 122(1):e202310061. PubMed ID: 37471507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
    Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
    Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapies for Primary Immune Deficiencies.
    Kohn LA; Kohn DB
    Front Immunol; 2021; 12():648951. PubMed ID: 33717203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for Wiskott-Aldrich syndrome: History, new vectors, future directions.
    Ferrua F; Marangoni F; Aiuti A; Roncarolo MG
    J Allergy Clin Immunol; 2020 Aug; 146(2):262-265. PubMed ID: 32623069
    [No Abstract]   [Full Text] [Related]  

  • 9. The Wiskott-Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation.
    Pille M; Avila J; Sanchez GS; Goetgeluk G; De Munter S; Jansen H; Billiet L; Weening K; Xue H; Bonte S; Ingels J; De Cock L; Pascal E; Deseins L; Kerre T; Taghon T; Leclercq G; Vermijlen D; Davis B; Vandekerckhove B
    Front Immunol; 2023; 14():1188099. PubMed ID: 37350958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-cell atlas of immunocytes in the spleen of a mouse model of Wiskott-Aldrich syndrome.
    Liang F; Peng C; Luo X; Wang L; Huang Y; Yin L; Yue L; Yang J; Zhao X
    Cell Immunol; 2023; 393-394():104783. PubMed ID: 37944382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wiskott-Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India.
    Basu S; Rikhi R; Arora K; Joshi V; Sharma S; Rawat A; Singh S; Suri D
    Pediatr Blood Cancer; 2024 Jun; 71(6):e30972. PubMed ID: 38523275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic hematopoietic stem cell transplantation outcome in oldest known surviving patients with Wiskott-Aldrich syndrome.
    Anantharachagan A; Loh SY; Burns SO; Laurence A; Tadros S; Tholouli E; Lwin Y; Martinez-Calle N; Vaitla P; Morris EC
    J Allergy Clin Immunol Glob; 2024 Feb; 3(1):100191. PubMed ID: 38187865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unraveling the repertoire in Wiskott-Aldrich syndrome.
    Petersen SH; Sendel A; van der Burg M; Westerberg LS
    Front Immunol; 2014; 5():539. PubMed ID: 25386182
    [No Abstract]   [Full Text] [Related]  

  • 14. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.
    Braun CJ; Boztug K; Paruzynski A; Witzel M; Schwarzer A; Rothe M; Modlich U; Beier R; Göhring G; Steinemann D; Fronza R; Ball CR; Haemmerle R; Naundorf S; Kühlcke K; Rose M; Fraser C; Mathias L; Ferrari R; Abboud MR; Al-Herz W; Kondratenko I; Maródi L; Glimm H; Schlegelberger B; Schambach A; Albert MH; Schmidt M; von Kalle C; Klein C
    Sci Transl Med; 2014 Mar; 6(227):227ra33. PubMed ID: 24622513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem-cell gene therapy for the Wiskott-Aldrich syndrome.
    Boztug K; Schmidt M; Schwarzer A; Banerjee PP; Díez IA; Dewey RA; Böhm M; Nowrouzi A; Ball CR; Glimm H; Naundorf S; Kühlcke K; Blasczyk R; Kondratenko I; Maródi L; Orange JS; von Kalle C; Klein C
    N Engl J Med; 2010 Nov; 363(20):1918-27. PubMed ID: 21067383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal Integration during T Lymphocyte Activation and Function: Lessons from the Wiskott-Aldrich Syndrome.
    Cotta-de-Almeida V; Dupré L; Guipouy D; Vasconcelos Z
    Front Immunol; 2015; 6():47. PubMed ID: 25709608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.
    Aiuti A; Biasco L; Scaramuzza S; Ferrua F; Cicalese MP; Baricordi C; Dionisio F; Calabria A; Giannelli S; Castiello MC; Bosticardo M; Evangelio C; Assanelli A; Casiraghi M; Di Nunzio S; Callegaro L; Benati C; Rizzardi P; Pellin D; Di Serio C; Schmidt M; Von Kalle C; Gardner J; Mehta N; Neduva V; Dow DJ; Galy A; Miniero R; Finocchi A; Metin A; Banerjee PP; Orange JS; Galimberti S; Valsecchi MG; Biffi A; Montini E; Villa A; Ciceri F; Roncarolo MG; Naldini L
    Science; 2013 Aug; 341(6148):1233151. PubMed ID: 23845947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.
    Morris EC; Fox T; Chakraverty R; Tendeiro R; Snell K; Rivat C; Grace S; Gilmour K; Workman S; Buckland K; Butler K; Chee R; Salama AD; Ibrahim H; Hara H; Duret C; Mavilio F; Male F; Bushman FD; Galy A; Burns SO; Gaspar HB; Thrasher AJ
    Blood; 2017 Sep; 130(11):1327-1335. PubMed ID: 28716862
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.